364 related articles for article (PubMed ID: 16928853)
1. Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia.
Nadjar A; Brotchie JM; Guigoni C; Li Q; Zhou SB; Wang GJ; Ravenscroft P; Georges F; Crossman AR; Bezard E
J Neurosci; 2006 Aug; 26(34):8653-61. PubMed ID: 16928853
[TBL] [Abstract][Full Text] [Related]
2. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.
Guigoni C; Doudnikoff E; Li Q; Bloch B; Bezard E
Neurobiol Dis; 2007 May; 26(2):452-63. PubMed ID: 17350277
[TBL] [Abstract][Full Text] [Related]
3. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
Betarbet R; Greenamyre JT
Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
[TBL] [Abstract][Full Text] [Related]
4. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
[TBL] [Abstract][Full Text] [Related]
5. Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.
Perez XA; Zhang D; Bordia T; Quik M
Mov Disord; 2017 Apr; 32(4):538-548. PubMed ID: 28256010
[TBL] [Abstract][Full Text] [Related]
6. The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.
Robertson RG; Clarke CA; Boyce S; Sambrook MA; Crossman AR
Brain Res; 1990 Oct; 531(1-2):95-104. PubMed ID: 2289139
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
Wei W; Ding S; Zhou FM
J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
Morin N; Jourdain VA; Morissette M; Grégoire L; Di Paolo T
Neuropharmacology; 2014 Apr; 79():688-706. PubMed ID: 24456747
[TBL] [Abstract][Full Text] [Related]
10. Diametric neural ensemble dynamics in parkinsonian and dyskinetic states.
Parker JG; Marshall JD; Ahanonu B; Wu YW; Kim TH; Grewe BF; Zhang Y; Li JZ; Ding JB; Ehlers MD; Schnitzer MJ
Nature; 2018 May; 557(7704):177-182. PubMed ID: 29720658
[TBL] [Abstract][Full Text] [Related]
11. Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.
Calon F; Goulet M; Blanchet PJ; Martel JC; Piercey MF; Bédard PJ; Di Paolo T
Brain Res; 1995 May; 680(1-2):43-52. PubMed ID: 7663983
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
Morin N; Morissette M; Grégoire L; Gomez-Mancilla B; Gasparini F; Di Paolo T
Neuropharmacology; 2013 Oct; 73():216-31. PubMed ID: 23756168
[TBL] [Abstract][Full Text] [Related]
13. Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia.
Farré D; Muñoz A; Moreno E; Reyes-Resina I; Canet-Pons J; Dopeso-Reyes IG; Rico AJ; Lluís C; Mallol J; Navarro G; Canela EI; Cortés A; Labandeira-García JL; Casadó V; Lanciego JL; Franco R
Mol Neurobiol; 2015 Dec; 52(3):1408-1420. PubMed ID: 25344317
[TBL] [Abstract][Full Text] [Related]
14. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling.
Deng YP; Lei WL; Reiner A
J Chem Neuroanat; 2006 Dec; 32(2-4):101-16. PubMed ID: 16914290
[TBL] [Abstract][Full Text] [Related]
15. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey.
Boraud T; Bezard E; Bioulac B; Gross CE
Brain; 2001 Mar; 124(Pt 3):546-57. PubMed ID: 11222455
[TBL] [Abstract][Full Text] [Related]
16. Direct modulation of firing activity by dopamine D
Zhu YC; Xue Y; Diao HL; Chen H; Liu HY; Han XH; Chen L
Sheng Li Xue Bao; 2016 Oct; 68(5):699-707. PubMed ID: 27778037
[TBL] [Abstract][Full Text] [Related]
17. Unmasking adenosine 2A receptors (A2ARs) in monkey basal ganglia output neurons using cholera toxin subunit B (CTB).
Luquin N; Sierra S; Rico AJ; Gómez-Bautista V; Roda E; Conte-Perales L; Franco R; McCormick P; Labandeira-García JL; Lanciego JL
Neurobiol Dis; 2012 Sep; 47(3):347-57. PubMed ID: 22659306
[TBL] [Abstract][Full Text] [Related]
18. The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia.
Perreault ML; Hasbi A; Alijaniaram M; Fan T; Varghese G; Fletcher PJ; Seeman P; O'Dowd BF; George SR
J Biol Chem; 2010 Nov; 285(47):36625-34. PubMed ID: 20864528
[TBL] [Abstract][Full Text] [Related]
19. Conditional ablation of striatal neuronal types containing dopamine D2 receptor disturbs coordination of basal ganglia function.
Sano H; Yasoshima Y; Matsushita N; Kaneko T; Kohno K; Pastan I; Kobayashi K
J Neurosci; 2003 Oct; 23(27):9078-88. PubMed ID: 14534241
[TBL] [Abstract][Full Text] [Related]
20. Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease.
Henry B; Duty S; Fox SH; Crossman AR; Brotchie JM
Exp Neurol; 2003 Oct; 183(2):458-68. PubMed ID: 14552886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
